Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Urine Proteome of COVID-19 Patients

Yanchang Li, Yihao Wang, Huiying Liu, Wei Sun, Baoqing Ding, Yinghua Zhao, Peiru Chen, Li Zhu, Zhaodi Li, Naikang Li, Lei Chang, Hengliang Wang, Changqing Bai, Ping Xu
doi: https://doi.org/10.1101/2020.05.02.20088666
Yanchang Li
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yihao Wang
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huiying Liu
2The Fifth Medical Center of PLA General Hospital, Beijing 100039, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Sun
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baoqing Ding
3Department of Ecology and Evolutionary Biology, University of Connecticut, 75 North Eagleville Road, Unit 3043, Storrs, CT 06269, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yinghua Zhao
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peiru Chen
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Zhu
4State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaodi Li
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naikang Li
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Chang
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hengliang Wang
4State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xuping@mail.ncpsb.org baicq307@163.com wanghl@bmi.ac.cn
Changqing Bai
2The Fifth Medical Center of PLA General Hospital, Beijing 100039, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xuping@mail.ncpsb.org baicq307@163.com wanghl@bmi.ac.cn
Ping Xu
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing 102206, China
5Key Laboratory of Combinatorial Biosynthesis and Drug Discovery of Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China
6Guizhou University School of Medicine, Guiyang 550025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xuping@mail.ncpsb.org baicq307@163.com wanghl@bmi.ac.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

SUMMARY

The atypical pneumonia (COVID-19) caused by SARS-CoV-2 is an ongoing pandemic and a serious threat to global public health. The COVID-19 patients with severe symptoms account for a majority of mortality of this disease. However, early detection and effective prediction of patients with mild to severe symptoms remains challenging. In this study, we performed proteomic profiling of urine samples from 32 healthy control individuals and 6 COVID-19 positive patients (3 mild and 3 severe). We found that urine proteome samples from the mild and severe COVID-19 patients with comorbidities can be clearly differentiated from healthy proteome samples based on the clustering analysis. Multiple pathways have been compromised after the COVID-19 infection, including the dysregulation of immune response, complement activation, platelet degranulation, lipoprotein metabolic process and response to hypoxia. We further validated our finding by directly comparing the same patients’ urine proteome after recovery. This study demonstrates the COVID-19 pathophysiology related molecular alterations could be detected in the urine and the potential application of urinary proteome in auxiliary diagnosis, severity determination and therapy development of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the MOST (2017YFC0906600 & 2017YFA0505002), the National Natural Science Foundation of China (31700723, 31670834, 31870824, 91839302 & 31901037), the Innovation Foundation of Medicine (16CXZ027, BWS17J032, AWS17J008 & 19SWAQ17), National Megaprojects for Key Infectious Diseases (2018ZX10302302), the Foundation of State Key Lab of Proteomics (SKLP-K201704), and the grant for Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences (2019RU006).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The accession numbers for the mass spectrometry proteomics data reported in this paper are the iProX (https://www.iprox.org/) dataset identifier: IPX0002166000. All the data will be publicly released upon publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 06, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Urine Proteome of COVID-19 Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Urine Proteome of COVID-19 Patients
Yanchang Li, Yihao Wang, Huiying Liu, Wei Sun, Baoqing Ding, Yinghua Zhao, Peiru Chen, Li Zhu, Zhaodi Li, Naikang Li, Lei Chang, Hengliang Wang, Changqing Bai, Ping Xu
medRxiv 2020.05.02.20088666; doi: https://doi.org/10.1101/2020.05.02.20088666
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Urine Proteome of COVID-19 Patients
Yanchang Li, Yihao Wang, Huiying Liu, Wei Sun, Baoqing Ding, Yinghua Zhao, Peiru Chen, Li Zhu, Zhaodi Li, Naikang Li, Lei Chang, Hengliang Wang, Changqing Bai, Ping Xu
medRxiv 2020.05.02.20088666; doi: https://doi.org/10.1101/2020.05.02.20088666

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (411)
  • Dentistry and Oral Medicine (68)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4837)
  • Forensic Medicine (3)
  • Gastroenterology (180)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (191)
  • Health Informatics (624)
  • Health Policy (318)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5310)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (92)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (684)
  • Nursing (42)
  • Nutrition (113)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (204)
  • Oncology (439)
  • Ophthalmology (139)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (777)
  • Public and Global Health (1806)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)